Business Context and Reporting Period
Company: Revelation Biosciences, Inc. (REVB)
Filing Type: Form 8-K (Current Report)
Date of Report: October 15, 2025
Event: Adjournment of the Special Meeting of Stockholders originally scheduled for October 15, 2025, due to the absence of a quorum. The meeting has been rescheduled for October 29, 2025.
Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes are reported in this document. The primary change is procedural: the Special Meeting of Stockholders was adjourned from October 15, 2025, to October 29, 2025, because a quorum was not present.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) confirming the adjournment of the stockholder meeting.
Risks and Contingencies: The filing notes that the information provided is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting its incorporation by reference in other filings. No specific financial risks or unusual items are detailed in this report.
Key Facts for Investor Verification
- Verify the agenda and proposed actions for the rescheduled Special Meeting of Stockholders on October 29, 2025.
- Confirm whether the adjournment impacts any pending corporate actions or deadlines associated with the original meeting.
- Review the attached press release (Exhibit 99.1) for additional context on the lack of quorum.
- Note that this 8-K contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.